FDA Revitalization Bill Progresses In Senate

Law360, New York (April 19, 2007, 12:00 AM EDT) -- A Senate Committee approved a bill Wednesday that would require the U.S. Food and Drug Administration to monitor safety of new drugs and renew a law allowing the agency to collect fees from drug companies and medical device manufacturers.

The bill, sponsored by Sens. Edward Kennedy (D-Mass.) and Michael Enzi (R-Wyo.) the chairman and ranking member of the Senate Health, Education, Labor and Pensions Committee, passed by a 15-5 vote.

The Prescription Drug User Fee Act, which allows the FDA to charge user fees for such...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.